Affected products
NANOSTIM LEADLESS CARDIAC PACEMAKER
As part of Abbott's post market surveillance and clinical trial monitoring processes, we have been made aware of docking button detachments that have occurred following implant or during attempted retrieval of Nanostim Leadless Cardiac Pacemaker (LCP) devices, model number S1DLCP. In all three cases that have occurred, there has been no impact to the electrical function (e.g., pacing, sensing, communication) and no clinical impact or symptoms resulting from the docking button detachment or exposed cables.